Scott Adam Elisofon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 14 | 2023 | 2119 | 1.640 |
Why?
|
| Biliary Atresia | 4 | 2019 | 73 | 1.190 |
Why?
|
| Choledochostomy | 1 | 2016 | 15 | 0.570 |
Why?
|
| Liver Diseases | 2 | 2021 | 1253 | 0.500 |
Why?
|
| Alagille Syndrome | 1 | 2010 | 35 | 0.380 |
Why?
|
| Organ Transplantation | 3 | 2023 | 1139 | 0.260 |
Why?
|
| Registries | 2 | 2021 | 8089 | 0.250 |
Why?
|
| Stents | 1 | 2016 | 3280 | 0.240 |
Why?
|
| Rubella | 1 | 2023 | 48 | 0.230 |
Why?
|
| Postoperative Complications | 4 | 2019 | 15295 | 0.230 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1425 | 0.220 |
Why?
|
| Mumps | 1 | 2023 | 64 | 0.220 |
Why?
|
| Chickenpox | 1 | 2023 | 131 | 0.220 |
Why?
|
| Measles | 1 | 2023 | 168 | 0.200 |
Why?
|
| Hepatitis B, Chronic | 1 | 2006 | 393 | 0.200 |
Why?
|
| Hepatoblastoma | 1 | 2022 | 87 | 0.200 |
Why?
|
| Activities of Daily Living | 1 | 2010 | 2418 | 0.200 |
Why?
|
| Cost of Illness | 1 | 2010 | 1859 | 0.190 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2019 | 16 | 0.170 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2020 | 134 | 0.170 |
Why?
|
| Child | 16 | 2023 | 77709 | 0.160 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2017 | 22 | 0.160 |
Why?
|
| Viral Vaccines | 1 | 2023 | 636 | 0.150 |
Why?
|
| Oxalates | 1 | 2017 | 105 | 0.150 |
Why?
|
| Hepatitis C, Chronic | 1 | 2006 | 1031 | 0.150 |
Why?
|
| Herpesvirus 8, Human | 1 | 2019 | 258 | 0.150 |
Why?
|
| Child, Preschool | 10 | 2023 | 41006 | 0.140 |
Why?
|
| Clostridium Infections | 1 | 2023 | 548 | 0.140 |
Why?
|
| North America | 1 | 2019 | 1249 | 0.140 |
Why?
|
| Sarcoma, Kaposi | 1 | 2019 | 370 | 0.130 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2020 | 388 | 0.130 |
Why?
|
| Pediatrics | 2 | 2020 | 3475 | 0.120 |
Why?
|
| Drainage | 1 | 2019 | 1142 | 0.120 |
Why?
|
| Infant | 8 | 2020 | 35136 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 770 | 0.120 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2014 | 142 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2016 | 547 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 581 | 0.100 |
Why?
|
| Nephrectomy | 1 | 2017 | 1050 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2013 | 272 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2013 | 165 | 0.100 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 4253 | 0.100 |
Why?
|
| Intestines | 1 | 2020 | 1924 | 0.090 |
Why?
|
| Tacrolimus | 1 | 2014 | 743 | 0.090 |
Why?
|
| Treatment Outcome | 9 | 2023 | 63114 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2019 | 25625 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2214 | 0.090 |
Why?
|
| Quality of Life | 1 | 2010 | 12804 | 0.090 |
Why?
|
| Neutropenia | 1 | 2014 | 895 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2019 | 3743 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2019 | 10252 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1179 | 0.070 |
Why?
|
| Adolescent | 5 | 2023 | 85781 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2014 | 1580 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 2538 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 25043 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2023 | 77449 | 0.060 |
Why?
|
| Hemangioma | 1 | 2009 | 738 | 0.060 |
Why?
|
| Humans | 20 | 2023 | 744343 | 0.060 |
Why?
|
| Chickenpox Vaccine | 1 | 2023 | 79 | 0.060 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 69 | 0.060 |
Why?
|
| Amlodipine | 1 | 2023 | 83 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 4251 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2023 | 342 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4149 | 0.050 |
Why?
|
| Male | 10 | 2023 | 350118 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2010 | 6459 | 0.050 |
Why?
|
| Health Surveys | 1 | 2010 | 4037 | 0.050 |
Why?
|
| JC Virus | 1 | 2020 | 85 | 0.040 |
Why?
|
| Female | 10 | 2020 | 380194 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 1392 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2019 | 258 | 0.040 |
Why?
|
| Polyomavirus Infections | 1 | 2020 | 197 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5442 | 0.040 |
Why?
|
| Health Status | 1 | 2010 | 4034 | 0.040 |
Why?
|
| Pressure | 1 | 2020 | 1203 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1850 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3658 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 2170 | 0.030 |
Why?
|
| Kidney | 2 | 2023 | 7186 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39050 | 0.030 |
Why?
|
| Liver | 2 | 2020 | 7474 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 1641 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 2029 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2021 | 2902 | 0.030 |
Why?
|
| ROC Curve | 1 | 2020 | 3527 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2013 | 216 | 0.030 |
Why?
|
| Hepatic Encephalopathy | 1 | 2013 | 139 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 4776 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2019 | 1708 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 1775 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1863 | 0.020 |
Why?
|
| Graft Survival | 1 | 2020 | 3737 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2240 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1836 | 0.020 |
Why?
|
| Biopsy | 1 | 2020 | 6756 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 2274 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3749 | 0.020 |
Why?
|
| Liver Failure | 1 | 2009 | 241 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 4665 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 35421 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
| Cytokines | 1 | 2016 | 7322 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40561 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12026 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12788 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10180 | 0.010 |
Why?
|
| Adult | 2 | 2023 | 214055 | 0.010 |
Why?
|
| Risk Factors | 1 | 2023 | 72290 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15540 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 163280 | 0.010 |
Why?
|